Difference between revisions of "2.16.840.1.113883.10.22.4.4/hgraph"

From HL7 IPS
Jump to: navigation, search
(Automatic ADBot page (bcf3585ac8c0b861f4b6fe28a2a4b286e0814d37))
(Automatic ADBot page (bcf3585ac8c0b861f4b6fe28a2a4b286e0814d37))
 
Line 20: Line 20:
 
                                 </li>
 
                                 </li>
 
                                 <li class="ad-template">
 
                                 <li class="ad-template">
−
                                     <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Subordinate SubstanceAdministration (2.16.840.1.113883.10.22.4.33)</li>
+
                                     <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)</li>
 
                             </ol>
 
                             </ol>
 
                         </li>
 
                         </li>
Line 27: Line 27:
 
             </tr>
 
             </tr>
 
         </table>
 
         </table>
−
<!--cd3583f3f03a445addbfc0d6f9969eea533d0fdd-->
+
<!--5023040cd8d964bdffd21d11932fc6eb5161be1e-->

Latest revision as of 05:13, 3 September 2021

  1. Entry
     IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
    1. Entry
       UV Use Period (2.16.840.1.113883.10.21.9.1)
    2. Entry
       IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
      1. Entry
         IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
    3. Entry
       IPS Body Author (2.16.840.1.113883.10.22.4.14)
      1. Entry
         IPS CDA Device (2.16.840.1.113883.10.22.9.2)
    4. Entry
       UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
Retrieved from "http://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.10.22.4.4/hgraph&oldid=8725"